FDA Sets High Bar for Prevention Agents as ODAC Votes Down Proscar And Avodart
Vanderbilt Wins NCI Core Grant Renewal with 12.7 Percent Funding increase
CTI Files Appeal Over FDA’s Decision on Pixantrone
NIH Defends NCI Sponsored Travel
Obituary: NCI’s Elaine Ron, Expert in Radiation Heath Effects
Trending Stories
- Mace Rothenberg’s museum will tell the stories behind breakthroughs in medicine
- Melanoma investigators invite FDA to publicly discuss approval endpoints and crossover design
The agency accepts the invitation - A $150M gift enables City of Hope to establish $1M Stephenson Prize in pancreatic cancer research, build research program focused on the disease
- Group chairs propose funding strategy to jump-start correlative studies
- Karen Knudsen to leave ACS
- 2024 Lasker Awards honor discoveries in antitumor immunity, GLP-1-based drugs, and research, advocacy in HIV/AIDS